Jim Cramer’s Game Plan: 15 Stocks in Focus

Page 4 of 14

11. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders: 61

Cramer mentioned that he expects Novo Nordisk A/S (NYSE:NVO) to forecast a good 2025 like its peer, Eli Lilly.

“Novo Nordisk, okay, now this is really interesting. See, this is the drug company behind Ozempic. They report. Now maybe they can give us clarity about how well these drugs are doing because Eli Lilly has already announced soft fourth-quarter sales but expects a very good 2025. Remember, we heard them when we were out in San Francisco. I’d like to hear the same thing from Novo Nordisk. If you do get good news from Novo Nordisk, get this, you might wanna buy some Eli Lilly before it reports on Thursday.”

Novo Nordisk (NYSE:NVO) specializes in the research, development, and production of pharmaceutical products. It is worth noting that over the past 5 years, LLY stock has gained a staggering 453% while NVO is up more than 165% during the same period.

Page 4 of 14